UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Assets of consolidated T. Rowe Price investment products | $ 2,117.2 | $ 1,959.3 |
| Liabilities of consolidated T. Rowe Price investment products | $ 71.1 | $ 54.2 |
| Stockholders' equity | ||
| Preferred stock, par value (in dollars per share) | $ 0.20 | $ 0.20 |
| Preferred stock, shares authorized (in shares) | 20,000,000 | 20,000,000 |
| Common stock, par value (in dollars per share) | $ 0.20 | $ 0.20 |
| Common stock, shares authorized (in shares) | 750,000,000 | 750,000,000 |
| Common stock, shares issued (in shares) | 223,494,000 | 223,938,000 |
| Goodwill | $ 2,642.8 | $ 2,642.8 |
| Variable interest entities | ||
| Assets of consolidated T. Rowe Price investment products | 1,229.2 | 1,204.4 |
| Liabilities of consolidated T. Rowe Price investment products | $ 27.7 | $ 35.2 |
| X | ||||||||||
- Definition Assets Of Voting Interest Entities And Variable Interest Entities No definition available.
|
| X | ||||||||||
- Definition Liabilities Of Voting Interest Entities And Variable Interest Entities No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|